Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2013 09:00 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Announces Additional Positive Efficacy and Patient Satisfaction Data From ATX-101 Phase III Trials for the Reduction of Submental Fat

CALABASAS, Calif., Oct. 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced additional patient satisfaction and efficacy data from REFINE-1 and REFINE-2, two...
September 19, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Appoints F. Michael Ball to Board of Directors

CALABASAS, Calif., Sept. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has named F. Michael (Mike) Ball, Chief Executive Officer (CEO) of Hospira, Inc....
September 16, 2013 17:26 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Announces Positive ATX-101 Top Line Phase III Trial Results for the Reduction of Submental Fat

CALABASAS, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that its ATX-101 REFINE-1 and REFINE-2 Phase III trials met all primary and...
August 06, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Second Quarter 2013 Operating Results

LOS ANGELES, Aug. 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its second quarter 2013, and provided an update on recent...
July 23, 2013 20:30 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release Second Quarter 2013 Operating Results

LOS ANGELES, July 23, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its second quarter 2013 operating results and will host an investor call...
June 06, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at Goldman Sachs 34th Annual Global Healthcare Conference

LOS ANGELES, June 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman...
May 13, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results

LOS ANGELES, May 13, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an update on recent...
May 07, 2013 16:30 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

LOS ANGELES, May 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of...
May 02, 2013 16:57 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release First Quarter 2013 Operating Results

LOS ANGELES, May 2, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its first quarter 2013 operating results and will host an investor call and...